Novartis Raises $2.1B By Selling Bonds Aimed At Improving Access To Medicines In LMICs
STAT: Novartis sells bonds tied to expanding access to medicines in poor countries
“In a first-of-its-kind move by a large drug maker, Novartis (NVS) raised approximately $2.1 billion last week by selling bonds that are tied directly to its progress in making medicines accessible in certain low- and middle-income countries…” (Silverman, 9/22).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.